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Open access unObjective: The purpose of this study was to investigate oxidative-stress parameters in individuals with chronic neck
or back pain after 5 weeks of treatment with high-velocity, low-amplitude (HVLA) spinal manipulation.
Methods: Twenty-three individuals aged 38.2 ± 11.7 years with nonspecific chronic neck or back pain verified by the
Brazilian Portuguese version of the Chronic Pain Grade, with a sedentary lifestyle, no comorbidities, and not in
adjuvant therapy, underwent treatment with HVLA chiropractic manipulation twice weekly for 5 weeks. Therapeutic
procedures were carried out by an experienced chiropractor. Blood samples were assessed before and after treatment to
determine the activities of the antioxidant enzymes superoxide dismutase (SOD), catalase and glutathione peroxidase
(GPx), and the levels of nitric oxide metabolites and lipid hydroperoxides. These blood markers were analyzed by
paired Student t test. Differences were considered statistically significant, when P was b .05.
Results: There was no change in catalase but an increase in SOD (0.35 ± 0.03 U SOD per milligram of protein vs
0.44 ± 0.04 U SOD per milligram of protein; P b .05) and GPx (7.91 ± 0.61 nmol/min per milligram of protein vs
14.07 ± 1.07 nmol/min per milligram of protein; P b .001) activities after the treatment. The nitric oxide metabolites
and the lipid hydroperoxides did not change after treatment.
Conclusion: High-velocity, low-amplitude spinal manipulation twice weekly for 5 weeks increases the SOD and
GPx activities. Previous studies have shown a relationship between pain and oxidative and nitrosative parameters;
thus, it is possible that changes in these enzymes might be related to the analgesic effect of HVLA spinal
manipulation. (J Manipulative Physiol Ther 2015;38:119-129)
Key Indexing Terms: Antioxidant Enzymes; Oxidative Stress; Manipulation; Spinal; Manual Therapy; Chiropractiche physiologic effects of vertebral manipulation the spinal biomechanical dysfunction known as vertebralTmay result from its effect on the flow of informationto the central nervous system.1,2 It is suggested that
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2rg/10.1016/j.jmpt.2014.11.003subluxation disturbs the neurologic function by sensitizing
paraspinal sensory afferents, especially the proprioceptors
and nociceptors in joints and muscles.3-6 This sensitization
possibly leads to plastic changes in cells of the central
nervous system.6 On the other hand, high-velocity, low-
amplitude (HVLA) spinal manipulation supposedly alters
the central sensory processing by favoring a nociceptive
modulation due to low-frequency stimulation of mechan-
onociceptors of paraspinal tissues, which contributes to
analgesia.4 This central modulation may also influence
muscle and visceral reflex responses.1,2,6
The peripheral sensitization after activation of nociceptors
and the subsequent central sensitization are associated with
neuronal excitability and the presence of pronociceptive
molecules locally.7,8 In pain conditions, there is an increase
in neural activity due to neuronal excitability, with more
utilization of metabolic substrates and increased production of
reactive oxygen and nitrogen species (RS).9,10 RS, which
include free radicals and peroxides, are normally formed in the
cell respiration process and play an important role in both
physiologic and pathologic conditions.11
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physiologic regulators in intracellular signaling pathways.12,13
In the development of persistent pain states, as occurs in nerve
injury or inflammatory insult, the increase in RS seems to be
essential not only for the induction but also for the
maintenance of central sensitization in the spinal cord.13-16
It is thought that hydrogen peroxide (H2O2), nitric oxide (NO),
and superoxide are the main RS involved in the central
sensitization process.17
An overwhelming production of reactive oxygen species
can generate oxidative stress, leading to deleterious effects on
cellular function.18 Oxidative stress occurs as a result of an
imbalance between increased production and/or reduced
degradation of oxygen reactive species. It may lead to
damage to lipids, protein, and DNA.18 To counteract reactive
oxygen species–induced cell damage, biological systems
have evolved endogenous mechanisms to protect themselves
in normal physiologic conditions.19 The cellular antioxidant
mechanisms involve nonenzymatic compounds and enzymes
such as superoxide dismutase (SOD), catalase, and glutathi-
one peroxidase (GPx).19,20 Superoxide dismutase is specific
to superoxide-radical detoxification. Superoxide dismutase
can rapidly dismutate the superoxide radical, yielding H2O2
and oxygen.21 Hydrogen peroxide is a diffusible reactive
oxygen species that contributes to the development of
pathologic pain states, not only by generating harmful reactive
species but also by modulating synaptic plasticity.22 The
presence of H2O2 apparently affects the release of intracel-
lular calcium, leading to neuronal sensitization and
pronociceptive patterns in interneurons in the spinal cord
dorsal horn.15 Catalase activity, in turn, converts H2O2 to
water.23 Furthermore, GPx is an important enzymatic
mechanism for the disposal of peroxides, producing water
or alcohol and reduced glutathione.24
Nitric oxide may react with the superoxide radical and
form peroxynitrite, a very deleterious nitrogen species, which
may lead to lipid and protein peroxidation and damage.17 In
addition, NO has a modulatory role in pain states at both the
central and peripheral levels.25,26 Nitric oxide has been
implicated in synaptic plasticity and multiple mechanisms
involving central sensitization.26 The involvement of NO in
peripheral nociception is corroborated by data demonstrating
the local release of NO by an inflammatory stimulus.27 Nitric
oxide plays a controversial role in pain modulation, that is,
NO can mediate nociception or induce an antinociceptive
effect.26 The modulatory effect of NO may be related to
neuronal excitability.25
In a previous study, we demonstrated a possible
correlation between HVLA manipulation and oxidative-
stress parameters. An increase in systemic catalase activity
was demonstrated after 6 sessions of HVLA manipulation in
2 weeks of treatment.28 Glutathione peroxidase activity, in
turn, seemed to require a longer period of treatment (N2
weeks) because only a tendency to increased activity was
found in the period considered.29 These results led us tohypothesize that the effects of HVLA spinal manipulation on
antioxidant activity may depend on the treatment period.
Therefore, to providemore information about this hypothesis,
the purpose of this study was to assess RS in blood of patients
with nonspecific chronic neck or back pain treated by HVLA
spinal manipulation for 5 weeks, twice a week, to analyze the
activity of the antioxidant enzymes SOD, catalase and GPx,
the levels of NO metabolites, and the formation of lipid
hydroperoxides (LOOHs), which are formed by the action of
reactive oxygen species on polyunsaturated fatty acids,30 in
the blood of the patients before and after the treatment.
METHODS
Subjects
This study selected individuals with nonspecific31
chronic neck or back pain as described by Guzman et al32
and Lawrence et al, 33 respectively. The criteria for
inclusion in the study were symptoms must be present for
at least 90 days34 and have an average intensity greater than
2 of 10 on a visual numerical pain scale.35 The exclusion
criteria were symptoms related to serious pathologies such
as malignancy, infection, inflammatory disorder, or frac-
ture. Patients were also excluded, when there were signs of
lumbar or cervical spinal cord compromise or radiculopathy
and/or a history of neck or back surgery. In addition,
subjects were only eligible for trial inclusion if spinal
manipulation was an appropriate therapy for their condi-
tion. The subjects had to be nonsmokers, not be on adjuvant
therapy, and have a sedentary lifestyle because exercise can
influence the biochemical parameters studied.36,37Experimental Procedures
Fifty subjects (18-60 years old) with chronic neck pain
or back pain were recruited through advertisements in the
local newspapers of Vale dos Sinos (free distribution,
13000 copies, May-July 2012; Jornal Bem Estar) and
advertisements in public agencies (Agência do Sistema
Nacional de Emprego e Fundação Gaúcha do Trabalho e
Ação Social, June 2011-2012; and City Hall of Novo
Hamburgo, August-December 2012). Each volunteer was
identified by a code during the selection process; the same
code was subsequently used to identify the records and
blood samples. An inclusion/exclusion questionnaire was
administered, and the history and a physical examination
were used to screen the participants. The frequency,
intensity, and disability of the symptoms were assessed
by the Brazilian Portuguese version of the Chronic Pain
Grade (CPG-Br), an adapted and validated version of the
original graded chronic pain scale from Von Korff et al.38,39
The CPG-Br evaluates self-perception of pain. The scale has
7 questions that assess pain intensity and disability. Six
questions request numerical scores ranging from 0 to 10,
including the pain intensity at themoment, in the worst phase,
and the average pain intensity. An additional question
Fig 1. Diagram shows the flow of participants through the course of the study. CPG-Br, Brazilian Portuguese version of the Chronic
Pain Grade; GPx, glutathione peroxidase; SOD, superoxide dismutase.
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pursue their usual activities due to pain.38 Twenty-five
individuals symptomatic for nonspecific chronic neck or back
pain were selected for this study (for more details, see Fig 1).
All selected subjects signed the required consent form before
beginning the study. The participants were subsequently
scheduled for the first blood-sample collection, 1 day before
the first session of treatment. Then, the subjects underwent 10
sessions of spinal HVLA manipulation (diversified tech-
niques), twice weekly for 5 weeks. High-velocity, low-
amplitude procedures were performed on all segments of the
spine with restriction of movement as determined by motion
palpation. Subjects with neck or back painwere considered as
a single group because they were given full spine adjustment.
Finally, 1 day after the treatment ended, the subjects gave a
final blood sample.
Blood samples were always drawn in the early hours of
the morning (from 7 AM to 9 PM). Patients were instructed to
fast for 8 hours and reduce their intake of sausages, red
meat, fat, chocolate, caffeine, citrus fruits, and whole grains
up to 24 hours before giving blood samples.40,41 The blood
samples were drawn from the cubital vein using disposableneedles and monovettes (BD Vacutainer, BD, Franklin
Lakes, NJ, cod. 367874) with anticoagulant heparin. The
first volume of blood (2 mL) was discarded to avoid
hemolysate material in the sample.41 Finally, 7 mL of venous
blood was quickly obtained and kept on ice until the
preparation of samples for later analysis.
The interview, treatment, and blood sampling were
performed in a private chiropractic clinic. The blood samples
were analyzed in the laboratories of the Physiology Depart-
ment of the Federal University of Rio Grande do Sul. The
therapeutic procedures were carried out by an experienced
doctor of chiropractic (N7 years of practice); the questionnaires
were administered by a second doctor of chiropractic, and the
blood samples were drawn by a nurse.
This study was approved by the Ethics Committee of the
Federal University of Rio Grande do Sul (no. 2008233). All
participants provided signed consent.
Blood Sample Preparation
Blood samples were centrifuged at 2700g for 20 minutes
in a refrigerated centrifuge (Sorvall RC 5B–Rotor SM 24;
DuPont Instruments, Wilmington, DE). Plasma samples
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metabolites and stored at −70°C. For analysis of LOOH, the
plasma was diluted 1:1 (vol/vol) in butylated hydroxytoluene
(2,6-di-tert-butyl-4-methylphenol) (90% in methanol) before
being stored.42 Red blood cells (RBCs) were washed 3 times
with cold 0.9 N phosphate-buffered saline. Aliquots of RBCs
were stored at−70°C in 1mmol/LHCl, and 4mmol/LMgSO4
buffer was diluted 50:500 (vol/vol) for later analyses of
enzymatic antioxidant activity.43
Determination of Antioxidant Enzyme Activities
In this study, CuZnSOD activity was determined. The
activity of SOD, expressed as units per milligram of protein,
was measured based on its action to neutralize the
superoxide radicals to prevent oxidation of adrenalin to
adrenochrome, a colorful byproduct that can be measured at
480 nm (Spectrophotometer SP22; Bioespectro, Curitiba,
Paraná, Brazil). Superoxide dismutase activity was deter-
mined by measuring the velocity of inhibition of adrenaline
oxidation. The reaction medium contained glycine buffer
(50 mmol/L, pH 11.3) and adrenalin (60 mmol/L, pH 2.0).44
Glutathione peroxidase activity was measured by after
nicotinamide dinucleotide phosphate acid oxidation at
340 nm (Spectrophotometer T60U; PG Instruments Lim-
ited, Leicestershire, UK) as described by Flohé and
Günzler.45 Glutathione peroxidase results were expressed
as nanomoles of peroxide/hydroperoxide reduced per
minute per milligram of protein.
Catalase activity was determined after the decrease in
absorption at 240 nm (Spectrophotometer T60U; PG Instru-
ments Limited) in a reaction medium containing 50 mmol/L
phosphate buffer (pH 7.2) and 10 mmol/L H2O2
46-48 and
expressed as picomoles of H2O2 reduced per minute per
milligram protein.
Protein Measurement
Protein was measured by the method of Lowry et al,49
using bovine serum albumin as standard.
Determination of NO Metabolites
Pure plasma samples without previous preparation or
dilution were analyzed for NO metabolites. To measure NO
metabolites, nitrites (NO2) were determined using the
Griess reagent, in which a chromophore with a strong
absorbance at 540 nm is formed by reaction of NO2 with a
mixture of 0.1% naphthylethylenediamine and 1% sulfa-
nilamide. Nitrates (NO3) were determined as total NO2
(initial NO2 plus NO2 reduced from NO3) after their
reduction using NO3 reductase from Aspergillus species in
the presence of nicotinamide dinucleotide phosphate acid.
A standard curve was established with a set of serial
dilutions (10−8 to 10−3 mol/L) of sodium NO2. Absorbance
at 540 nm was obtained (spectrophotometer, Zenyth 200;
Anthos, Eugendorf, Austria). Results were expressed as
micromoles of NO2 plus NO3 per liter.
50Determination of LOOHs
Themethod is based on oxidation of iron ferrous (Fe2+) to
the ferric form (Fe3+) in the presence of LOOHs and
formation of complexes of Fe3+ with xylenol orange.30,51
According to the technique adapted from Sodergren et al,42
for each sample, a blank reduced with triphenylphosphine
(TPP) 10 mmol/L in absolute methanol was used.
At the time of the test, a working reagent was prepared with
81% (vol/vol) of 90% methanol, 2 mmol/L xylenol orange
(o-Cresolsulfonphthalein-3′-3″-bis [methyliminodiacetic acid
sodium salt]) to a final concentration of 100 μmol/L, 1 mol/L
sulfuric acid to a final concentration of 25mmol/L, 40mmol/L
2,6-di-tert-butyl-4-methylphenol to a final concentration of
4 mmol/L, and 10 mmol/L ferrous sulfate to a final
concentration of 250 μmol. Samples were prediluted 1:10 in
Milli-Q (Direct-Q3, Millipore SAS, Molsheim, France) water
before the test. Then, theywere divided into 2 tubeswith 90μL
of sample in each. The samples were incubated for 30 minutes
with 10μL of 90%methanol or 10μL of 1mmol/L TPP. After
incubation, the samples were pipetted in duplicate in the
microplate and incubated with working reagent (1:9) with
stirring for 1 hour at room temperature. Absorbance at 560 nm
was obtained (spectrophotometer, Zenyth 200; Anthos), and
the absorbance values of the duplicates obtained with TPP
were subtracted from the values for the duplicateswithout TPP.
Results are expressed in nanomoles of LOOHs per milligram
of protein.
Statistical Analysis
For statistical analysis, subjects with neck or back pain
were considered as a single group. The comparison was
made before and after treatment, independently of the pain
location and for each blood marker assessed. Data were
analyzed with the Sigma State package version 3.1 (Systat
Software Inc, Chicago, IL) for Windows. Statistical
differences were analyzed by paired Student t test.
Differences were considered statistically significant, when
P was b .05.
RESULTS
Initially, 28 subjects were eligible for the study but 3
declined to participate, giving an initial sample of 25 patients.
No patients were lost during the course of the treatment, but at
the final blood collection, it was not possible to draw enough
blood for the analyses from 2 patients. Thus, the final sample
size involved 23 subjects (Fig 1). Determinations of the
antioxidant enzymes SOD and catalase were obtained from
all patients. The GPx activity was determined for 21 patients
(2 missing samples). Because of the presence of hemolysate
in the plasma sample, determinations of NO metabolites and
LOOHs were obtained from 21 and 19 patients, respectively.
No severe adverse effects were reported by any participant
during the treatment; a few patients reported mild soreness at
the site of the vertebral segment manipulated.
Table 1. Demographic and Clinical Characteristics of Subjects
n = 23
Mean age ± SD, y 38.2 ± 11.7
Female/male 18/5
Mean body mass index ± SD, kilograms per square meter 24.9 ± 4.1
Patient complaints a
Neck pain 45%
Low back pain 14%
Neck pain and low back pain associated 41%
a Distribution of patients according to the location of painful complaints.
Table 2. Classification on CPG-Br
n = 23
Grade 0 (no pain) 0%
Grade I (low intensity) 5%
Grade II (high intensity) 45%
Grade III (moderately limiting) 30%
Grade IV (severely limiting) 20%
Pain disability
Low disability (grade I and II) 50%
High disability (grade III and IV) 50%
Pain intensity a (mean ± SD) 6.9 ± 1.3
Distribution of patients according to the classification on CPG-Br.
a Arithmetic mean of the reported pain at the moment, the worst pain
and the middle pain, according to CPG-Br.
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The demographic characteristics of the subjects are
shown in Table 1. The characteristics of the pain of the neck
or back were reported by the patients using the CPG-Br and
are shown in Table 2. According to the CPG-Br, half of the
patients had disabling pain, and of these, one-third had
severely limiting symptoms and the others only a
moderately limiting condition. Almost all of the remaining
subjects had pain of high intensity but slightly limiting, and
only 1 patient had pain of low intensity and not limiting.
Overall, mean pain intensity was greater than 50% on a
10-point visual numerical pain scale, wherein the charac-
teristics of pain at the moment, in the worst phase, and the
average pain intensity were considered.Antioxidant Enzyme Activities
The SOD and GPx activities were significantly higher
after 10 sessions of HVLA spinal manipulation for 5 weeks
(SOD: pretreatment, 0.35 ± 0.03 U SOD per milligram of
protein, posttreatment, 0.44 ± 0.04 U SOD per milligram of
protein; P = .005) (GPx: pretreatment, 7.91 ± 0.61 nmol/min
permilligram of protein, posttreatment, 14.07 ± 1.07 nmol/min
per milligram of protein; P b .001; mean ± SEM) (Fig 2).
Considering the general average of the SOD and GPx
activities of patients, the increase after the treatment was
around 27% for SOD (Fig 2A) and more than 77% for GPx
(Fig 2B) activities. The catalase activity, in these experimen-
tal conditions, did not show any significant change after the
treatment (pretreatment, 3.72 ± 0.19 pmol/min per milligram
of protein, posttreatment, 4.25 ± 0.35 pmol/min permilligram
of protein; P N .05) (Fig 2C).Nitric Oxide Metabolites
The NO metabolites (NO2 + NO3) showed no significant
change in the plasma from patients with nonspecific chronic
neck or back pain treated by HVLA spinal manipula-
tion (Fig 3A). The level of NO metabolites was 78.32 ±
6.73 μmol/L before treatment, whereas in posttreatment was
81.81 ± 7.12 μmol/L.,Lipid Hydroperoxides
Similarly to NO metabolites, no significant difference
was found in the LOOHs levels of the plasma from patients
with nonspecific chronic neck or back pain treated by
HVLA spinal manipulation (Fig 3B). The total amount of
plasmatic LOOHs was 4.33 ± 3.4 nmol/mg of protein in
pretreatment and 5.89 ± 5.0 nmol/mg in posttreatment.DISCUSSION
The present study demonstrated that treatment twice
weekly for 5 weeks of individuals with nonspecific chronic
neck or back pain by HVLA spinal manipulation increased
SOD and GPx activities, with no significant changes in
catalase activity, LOOHs, or NO metabolites in the systemic
blood. In our previous study, in contrast, catalase activity
increased after 6 interventions of HVLA spinal manipulation
in patients with neck pain, whereas no significant change was
observed in SOD and GPx activities. However, GPx activity
showed a tendency to increase with a shorter period of
treatment.28,29 These results suggest that the effect of HVLA
spinal manipulation on antioxidant enzyme activities may be
affected by the length of time and the frequency of treatment.
Before discussing our results, it is necessary to note some
considerations. In the present study, no control group (a
group without pain) was used. The absence of this group is
because our pretreatment values for the SOD, catalase and
GPx activities, and NOmetabolites showed a similar range to
that described in the literature for healthy individuals.52-54
The choice not to include a control group also took into
account previous studies that assessed oxidative parameters
in blood, without a healthy control group.55,56
Our result showed no changes in the LOOH levels. It is
possible that the lack of change in LOOHs may be due to the
increase in antioxidant enzyme activities and the availability
of NOmetabolites. The presence of LOOHs causes oxidative
stress-mediated damage by the action of peroxynitrites and
hydroperoxides on polyunsaturated fatty acids.30 The rise in
SOD activity reduces the availability of the superoxide
Fig 2. Antioxidant activity of SOD (expressed units of SOD per
milligram of protein) (n = 23) (A), GPx activity (expressed as
nanomoles per minute per milligram of protein) (n = 21) (B), and
catalase (expressed as picomoles per minute per milligram
protein) (n = 23) (C) in RBCs from patients with nonspecific
chronic neck or back pain. Data are represented as mean ± SEM
⁎P b .05 (paired Student t test).
Fig 3. Determination of NO metabolites (NO2+NO3
(expressed as micromoles per liter) (n = 21) (A) and LOOHs
(expressed as nanomoles per milligram of protein) (n = 19) (B
in plasma from patients with nonspecific chronic neck or back
pain. Data are represented as mean ± SEM. There was no
significant difference after treatment (paired Student t test)
SOD, superoxide dismutase.
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a harmful oxidant agent.17,57 Glutathione peroxidase catalyzes
the reduction of H2O2 and organic hydroperoxides at the
expense of glutathione. It also functions as a defense against
peroxynitrite-mediated oxidations.58 Thus, the increase in the
SOD and GPx activities may be contributing to prevent the
increase of peroxynitrite. Furthermore, it is known that in pain)
)
.processing or in injury to neural tissue, there is involvement of
reactive species including superoxide, NO, and
peroxynitrite.15,16,57,59 Thus, the increase in SOD activity,
which decreased the availability of superoxide, may be one
contributing factor to the analgesic effect of the HVLA spinal
manipulation treatment because no change was found in NO
metabolites in our study.
However, the dismutation of superoxide radicals results in
H2O2 formation.
21 Hydrogen peroxide has a high damage
potential and also contributes to central sensitization.16 It
appears to release intracellular stored calcium, and in this way
affects synaptic activity in dorsal horn interneurons, leading to
sensitization of these neurons and pronociceptive patterns.22
However, H2O2 does not have only deleterious effects. At
moderate concentrations, H2O2 can act as an intracellular
messenger that modulates neurotransmitter systems.58 Thus,
it is important to maintain the intracellular concentrations
within physiologic levels, restricting somewhat the increase
of this molecule that would occur with the increase in
antioxidant enzyme activity.
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detoxification of H2O2.
60 An increase in the activity of these
enzymes in any conditions indicates a decrease in H2O2
levels. Our previous results demonstrated that catalase
activity increased after the third session of HVLA spinal
manipulation and was higher after 6 sessions.28 However, we
described only a tendency to an increase in GPx activity.29 In
the present study, HVLA spinal manipulation for 5 weeks did
not induce a significant change in catalase but did increase
GPx activity. These changes can regulate the concentrations
of H2O2 in erythrocytes. At moderate concentrations, H2O2
maintains its beneficial intracellular functions.58 The change in
the activity of catalase and GPx in different periods after
treatment byHVLAspinalmanipulation appears to indicate that
this treatment, directly or indirectly, induced these changes,
although they appear to depend on the period of intervention.
It is possible that the effects on RS of the length of time
and the frequency of the treatment by HVLA spinal
manipulation may be related to the response of the immune
system. Studies have demonstrated a close relationship
between the oxidative stress balance and the immune
system. Cytokines may induce SOD expression, which
appears to protect the normal tissue from damage.61 Some
cytokines, such as tumor necrosis factor α (TNF-α) and
interleukin 1β (IL-1β) and some reactive-oxygen interme-
diates are involved in the process of signal transduction that
leads to activation of the SOD gene.61,62 Interleukin 6
(IL-6) may also indirectly favor SOD expression by
enhancing IL 1 and TNF-α, which magnifies the effect of
these cytokines on SOD expression.61 The relationship
between cytokines and SOD activity must be interpreted
with caution because the gene expression of SOD and its
enzymatic activity may be regulated by different factors
and independently of each other.63
Some studies suggest an increase in proinflammatory
cytokines in the blood of patients with neck or lower back
pain of mechanical origin.64,65 In turn, the treatment with
spinal manipulation appears to decrease the proinflamma-
tory cytokines.65-68 Subjects treated with a single spinal
manipulation therapy showed a time-dependent attenuation
of lipopolysaccharide-induced production of the inflamma-
tory cytokines TNF and IL-1β.68 Chiropractic manipulation
(activator method) for 2 weeks induced a tendency to
reduction in IL-6 levels.65 Interestingly, comparison
between this and our previous results shows that the
reduction of IL-6 coincided with the tendency to reduction
in SOD activity.29 Thus, it is possible that the lower SOD
activity after the patients with neck pain who were treated
by HVLA spinal manipulation for 2 weeks may be due to
the reduction in proinflammatory cytokines, probably IL-6.
It would be interesting to examine the relationship between
proinflammatory cytokines and RS parameters in patients
treated by HVLA spinal manipulation.
In tissue inflammation, not only the reactive oxygen
species was increased but also NO production.17 Nitricoxide is a gaseous free radical that is synthesized from L-
arginine and may act as an important regulator of
vasoregulation, neuronal transmission, immune response,
and cell apoptosis.69 Excessive production of NO after
induction of calcium-independent inducible NO synthase
has been proposed as a major factor involved in tissue
damage.69 Interestingly, Mazzetti et al70 found high levels
of NO metabolites in chondrocytes stimulated with IL-1β
and TNF-α, and these levels were higher in chondrocytes
from patients with osteoarthritis than in those patients with
rheumatoid arthritis. An animal model of joint immobili-
zation showed reversible neurodegenerative changes,
which were related, in part, to NO-mediated oxidative
stress.71 In addition, levels of NO metabolites were higher
in individuals with mechanical neck pain compared with
healthy controls, which are probably related to the
activation of proinflammatory mediators.64
Despite the wider variation in values of the NO
metabolites in our study, the values were similar to those
found by Teodorczyk-Injeyan et al.64 This study found
levels from 12 to 106 μmol/L in patients with pain, whereas
our results ranged from 47 to 161 μmol/L. However, we
determined NO2 plus NO3 levels, whereas they determined
only NO2 levels. According to these authors, high levels of
NO combined with neuronal sensitization could contribute
to the genesis of the pain state. The vertebral manipulation
response, in turn, could down-regulate inflammatory
mediators.66-68 Our data are consistent with the assumption
that NO contributes to pain symptoms. However, it is
interesting that no significant change was observed in NO
metabolites after the HVLA spinal manipulation. In
agreement with our findings, another study with HVLA
spinal manipulation showed no alteration in plasma levels
of NO in healthy subjects, either immediately or 2 hours
after the intervention.72 The same authors found only a
correlation with the pain sensitivity at the pressure-pain
threshold. These authors suggested that NO can be involved
in pain sensitization but may not be a key element in the
analgesic effects of spinal manipulation. Our results
reinforce this hypothesis.
However, it is necessary to use caution in analyzing the
relationship between NO and HVLA spinal manipulation.
Our study showed that this treatment increases GPx
activity. This enzyme catalyzes the reduction of H2O2 and
organic hydroperoxides at the expense of glutathione.24
Some authors have considered glutathione as an addi-
tional cofactor required for maximum activity of NO
synthase, the enzyme responsible for synthesis of NO.73
An increase in GPx activity induces greater consumption
of glutathione. Thus, it can be hypothesized that the
relationship between NO, glutathione, and GPx has some
role in the lack of changes in NO after treatment by HVLA
spinal manipulation.
Themaintenance ofNO levelsmay explain in part why the
increase in SOD activity was not as pronounced as the
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SOD activity is inhibited in the presence of increases in
NO formation.74 Further studies demonstrating the
relationship between NO formation and SOD expression
will be necessary to clarify the relationship between
these molecules in patients with pain treated by HVLA
spinal manipulation.
High-velocity, low-amplitude manipulation may cause
changes not only in neuronal excitability but also in other
physiologic parameters.2,4-6 We demonstrated again that
the HVLA spinal manipulation affects the oxidative status
by increasing the activity of the antioxidant enzymes SOD
and GPx. In contrast to our previous studies that showed an
increase only in catalase activity, the activity of this enzyme
did not change in the experimental conditions used here. In
addition, we observed no significant changes in LOOHs
and NO metabolites. Because the main difference between
the studies was the length of time and the frequency of
interventions by HVLA spinal manipulation, our results
reinforce our hypothesis that the length of time and the
frequency of the HVLA treatment are the determinants for
these changes in the antioxidant activity in patients with
nonspecific chronic neck or back pain. It is possible that the
combination of factors such as neuronal excitability,
inflammatory response, and oxidative status may be
responsible for the entire picture and possibly make some
difference in pain attenuation. The most important aspect is
that HVLA spinal manipulation increases the activity of
antioxidant enzymes. Because the literature shows a
relationship between pain and oxidative and nitrosative
parameters, changes in these enzymes might be related to
the analgesic effect of HVLA spinal manipulation.Limitations
This study was performed with HVLA spinal manipula-
tion treatment for 5 weeks, twice a week, in subjects with
nonspecific neck or back pain, without a control group. It
would be more enlightening to have a healthy control group
under the same experimental procedures and also to have a
control group of a different therapeutic modality or sham
manipulation. It is necessary to consider that this study was
not blind, and some placebo effect may have occurred. In
addition, it is important to consider the time of the blood
collection. In this study, blood was drawn 1 day after the end
of treatment. We suggest that future studies assess oxidative
and nitrosative parameters in blood collected at different
times, including during the interval of treatment, for example,
after 1 session of HVLA spinal manipulation. It is also
necessary to analyze the oxidative and nitrosative parameters
in the serum. The determinations should also include
cytokines. Data obtained for women and men require caution
in the interpretation because of the systemic influence of
female hormones on pain sensitivity. Finally, in future
studies, the number of patients should be increased.CONCLUSION
Our study showed that SOD and GPx activity but not
catalase activity of the RBCs of patients with nonspecific
chronic neck or back pain increased after 10 sessions of
HVLA spinal manipulation. This treatment did not induce
significant changes in the LOOHs and NO metabolites in
the plasma of these patients. Although it is too early to
speculate on the role of oxidative and nitrosative species
in HVLA treatment, the results of the present study
support the hypothesis that the effects of HVLA spinal
manipulation on oxidative and nitrosative species depend
on the length of time and the frequency of treatment.
Because previous studies have shown a relationship
between pain and oxidative and nitrosative parameters,
changes in these enzymes might be related to the
analgesic effect of HVLA spinal manipulation. However,
further studies on this topic are crucial for better
understanding of the temporal relationship between
oxidative and nitrosative parameters and HVLA treatment.
This study provides preliminary data for a randomized
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Practical Applications
• This study found that HVLA spinal manip-
ulation therapy results in increase of enzy-
matic antioxidant activities depending on the
length of time and frequency of treatment.
• Once there is a relationship between pain and
oxidative and nitrosative parameters, changes in
the antioxidant enzymes might be related to the
analgesic effect of HVLA spinal manipulation.
• Larger study with a control group should be
performed to assess the antioxidative profile
and to relate these findings with the analgesic
effect of spinal manipulation therapy.
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